Nirvana Life Sciences Inc.
NIRVX
CNSX
| 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -256.80K | -266.90K | -246.30K | -260.70K | -397.40K |
| Total Depreciation and Amortization | -- | -- | -- | -- | 4.50K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 18.30K | -127.20K | -106.40K | -106.40K | 18.20K |
| Change in Net Operating Assets | -523.00K | -491.90K | -509.30K | 199.50K | 220.80K |
| Cash from Operations | -761.50K | -886.00K | -861.90K | -167.50K | -153.80K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 141.80K | 179.80K | 155.80K | 156.10K | 90.50K |
| Total Debt Repaid | 85.80K | 85.80K | 85.80K | 85.80K | 50.00K |
| Issuance of Common Stock | 950.00K | 950.00K | 950.00K | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -59.10K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 400.00 | -800.00 | -800.00 | -- | 9.10K |
| Cash from Financing | 853.30K | 878.90K | 862.10K | 171.40K | 65.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -85.70K | 8.50K | -1.30K | -3.50K | 81.20K |
| Net Change in Cash | 6.10K | 1.60K | -1.00K | 500.00 | -7.50K |